The development of novel technologies has resulted in new ways to study cardiac function and rhythm disorders (Shaheen et al., 2018). One such technology is the induced pluripotent stem cell-derived cardiomyocyte (iPSC-CMs) in vitro model system (Leyton-Mange et al., 2014). The iPSC-CM system constitutes a powerful in vitro tool for preclinical assessment of cardiac electrophysiological impact and drug safety liabilities in a human physiological context (Sun et al., 2012; Lan et al., 2013; Burridge et al., 2016; Doss and Sachinidis, 2019; Collins et al., 2020; Wu et al., 2019). Moreover, because iPSC-CMs can be cultured from patient-specific cells, it has shown to be an ideal model system for patient-based medicine (Wu et al., 2019; Sayed et al., 2016; Matsa et al., 2016).

While utilization of in vitro iPSC-CMs allows for testing of responses to drugs and understanding physiological mechanisms (Tveito et al., 2018; Tveito et al., 2020; Sube and Ertel, 2017; Navarrete et al., 2013), there is still a major inherent limitation of the approach: the complex differentiation process to create iPSC-CMs results in a model of cardiac electrical behavior that resembles fetal cardiomyocytes. Hallmarks of the immature phenotype include spontaneous beating, immature calcium handling, presence of developmental currents, and significant differences in the relative contributions of repolarizing potassium currents compared to adult cardiomyocytes (adult-CMs) (Lieu et al., 2013; Veerman et al., 2015; Tu et al., 2018). The profound differences between the immature iPSC-CMs and the adult-CMs have led to persistent questions about the utility and applicability of the iPSC-CM action potential (AP) to predict relevant drug impacts on adult human electrophysiology (Blinova et al., 2018; Sala et al., 2017).

Several recent studies have proposed computational frameworks to address the primary limitation in using iPSC-CMs and animal cardiomyocytes for drug screening (Tveito et al., 2018; Tveito et al., 2020; Gong and Sobie, 2018; de Korte et al., 2020). The innovative studies described by Tvieto and colleagues (Sayed et al., 2016; Matsa et al., 2016) presented a translation algorithm that identified a mapping function to identify the relationships between the parameters that are defined by key ion channel conductances in the iPSC-CM APs and the adult-CM APs. In another study by Gong and Sobie, additional insights were revealed through application of an efficient partial least squares regression (PLSR) methodology to translate key physiological features between iPSC-CMs and adult-CMs. They also demonstrated the potential to translate between species, between drug-free and simple drugged models, as well as between healthy and diseased phenotypes (Gong and Sobie, 2018). Koivumäki et al. also tried to address the problem of iPSC-CMs immaturity by establishing a novel in silico mathematical model for iPSC-CMs, which can estimate adult-CM behavior (Koivumäki et al., 2018).

The efficacy of the linear translation algorithms used in the earlier studies relies on a collection of underlying assumptions (Gong and Sobie, 2018). One described by Tvieto et al. is that cardiac protein expression levels would differ but their functional properties remain invariant during maturation and that a drug will modify protein function in the same way for iPSC-CMs and the adult-CMs (Tveito et al., 2018). Tvieto et al. also acknowledged the difficulty in minimizing the cost function that measures the differences between the initial and target parameters, which therefore required a brute force search algorithm for minimization. One possible explanation for the difficulty in cost function minimization is that linear translation may not capture the nonlinearities comprising the actual underlying physiological differences (Gong and Sobie, 2018). Another underlying assumption with linear translation is the required representation of drug effects as a simple pore block, modeled as a reduction in the maximal conductance of the channel (Tveito et al., 2018; Gong and Sobie, 2018). The earlier studies employed a biased method in that they rely on a priori parameter identification and extraction from voltage and calcium traces to allow feature mapping from immature to mature conditions (Tveito et al., 2018; Gong and Sobie, 2018). Earlier translators must also consider drug-free and drugged conditions independently.

In this study, we describe a deep learning multitask network that simultaneously performs translation and classification of signals from simulated cardiac myocytes for both drug-free and drugged conditions and demonstrate its utility for translating and predicting experimental data as well. The multitask network is an unbiased approach in that the user does not predefine the important parameters of the system. Rather, the network learns from the data to define important parameter regimes and data ranges. The new approach is indifferent to the underlying form of the models and can translate time-series data from any source. Moreover, the deep learning approach accepts nonlinearity of the system, makes no assumptions about changes in cardiac protein expression and function during maturation, and can successfully translate simple pore block and complex conformation state-dependent channel–drug interaction. The network learns from all of these data sources suggesting its broad applicability, but it requires multiple quality datasets for robust and successful translation. In addition, the multitask behavior of the network presents a single process that can perform translating any cardiac AP into the subject of perturbation.

There are multiple reasons why cell classification was considered in the study. Importantly, iPSC-CMs are generally used to understand how perturbation to the cells will result in a change to cardiac electrophysiology. Genetic and drug-induced perturbations have been commonly studied using iPSC-CM lines. An important aspect iPSC-CMs is the inherent variability reported in measurements. Indeed, wide-ranging behavior has been reported to spontaneously occur even from cells cultured from the same genetic line. Thus, it can be difficult at times to determine if a perturbation indeed has an effect compared to a control cell. Therefore, one purpose of the classification task as described in this study is to allow sorting of cells into categories without perturbation and cells that have undergone perturbation. The classification task allows us to then address the question of whether translation is effective in the setting of perturbation. We demonstrate here the efficacy of a deep learning network to perform classification in the example setting of a drug-induced perturbation.

Artificial neural networks (ANNs) are increasingly used to advance personalized medicine (Alhusseini et al., 2020; Rogers, 2020; Sevakula et al., 2020; Jin et al., 2009; Trayanova et al., 2021). Long-short-term-memory (LSTM)-based networks, which are capable of learning order dependence in sequence prediction problems (Hochreiter and Schmidhuber, 1997), have been widely used for cardiac monitoring purposes (Guo et al., 2021; Shi et al., 2021; Picon et al., 2019). They have been used to extract important biomarkers from raw ECG signals (Ballinger, 2018; He et al., 2019; Hou et al., 2019) and help clinicians to accurately detect common heart failure biomarkers in ECG screenings (Ballinger, 2018; Warrick and Homsi, 2017; Oh et al., 2018; Chen et al., 2020; Wang and Zhou, 2019; Bian, 2019). LSTM networks, which can catch existing temporal information in the electronic health records (EHRs), have been highlighted as the best predictive models using real-time data (Maragatham and Devi, 2019). LSTM-based classifiers have also empowered early arrhythmia detection by automatically classifying arrhythmias using ECG features (Yildirim et al., 2019; Wang et al., 2019; Martis et al., 2013; Liu et al., 2019; Yildirim, 2018). In addition, deep learning algorithms have been employed to predict drug-induced arrhythmogenicity associated with blockade of the delayed rectifier K⁺ channel current (I_Kr) in the CMs encoded by human ether-à-go-go-related gene (hERG) (Yang et al., 2020) for sets of small molecules in drug discovery and screening process (Yang et al., 2020; Cai et al., 2019; Zhang et al., 2019; Dickson et al., 2020; Ryu et al., 2020; Li et al., 2020).

Here, we implemented a deep learning LSTM-based multitask network to classify iPSC-CM AP traces into drug-free and drugged categories and translate them into adult-CM AP waveforms. To collect robust realistic simulated data for training the multitask network, we paced simulated cardiac myocytes with the addition of a physiological noise current at matching cycle lengths for Kernik in silico iPSC-CMs (Kernik et al., 2019) and O’Hara–Rudy in silico human adult-CMs (O'Hara et al., 2011) to generate a population of drug-free simulated cardiac myocyte data. To ensure that our model could perform for both drug-free and drugged iPSC-CM and adult-CM APs simultaneously, we simulated drugged samples via both a simple drug-induced I_Kr block model of hERG channel conduction, G_Kr, reduction by 1–50% and a complex Markov model of conformation-state dependent I_Kr block in the presence of a clinical concentration, 2.72 ng/mL, of a potent hERG blocking drug dofetilide from our recent study (Yang et al., 2020). We evaluated the multitask network performance on a test dataset and showed excellent performance to translate and classify signals in the form of time-resolved AP traces. We performed ablation studies to reveal the most important iPSC-CM AP information for classifying AP traces into drug-free and drugged categories and network translation into adult-CM APs by removing iPSC-CM AP values during various time frames (feature ablation). We also explored the importance of individual LSTM network building blocks and how decoupling of the translation and classification tasks affected overall network performance. We then showed how the proposed multitask network can be applied even to scarce experimental data, which was also used to validate the model.

In this study, we show that developments in iPSC-CM experimental technology and cardiac electrophysiological modeling and simulation of iPSC-CMs can be leveraged for the application of ANNs as a universal approximator (Goodfellow et al., 2016) to find the most accurate mapping function that is capable of learning nonlinear relationships to predict disease phenotype and drug response in cardiac myocytes from immaturity to maturation.

In this study, we set out to build a multitask network that would perform two distinct tasks: the first task is to classify iPSC-CM APs into drug-free and drugged categories. The second goal is to translate iPSC-CM APs into corresponding adult-CM AP waveforms. To collect the data for training the multitask network, we simulated a population of 208 AP waveforms for both Kernik in silico human iPSC-CMs (Kernik et al., 2019; Figure 1E, blue) and O’Hara–Rudy in silico human adult-CMs (O'Hara et al., 2011; Figure 1F, blue). We ensured consistency across a population of simulated myocytes by applying physiological noise at matching the cycle lengths into the iPSC-CMs and adult-CMs. The cell variability in each population is intended to represent the individual variability that is observed in a drug-free human population (Kernik et al., 2019; O'Hara et al., 2011; Tanskanen and Alvarez, 2007). An average AP trace from the population is shown in Figure 1A for iPSC-CMs and Figure 1B for adult-CMs. In Figure 1C, D, the ionic currents underlying the in silico iPSC-CM APs and adult-CM APs show marked differences, one reason for the broadly expressed concerns about the applicability of utilizing immature iPSC-CM APs in the study of human disease and pharmacology. The substantial current differences illustrate the necessity of a generalized approach to perform translation from immature myocytes into mature myocytes. To ensure that our multitask network could perform over a range of conditions and model forms, we simulated drugged iPSC-CM and adult-CM APs via both a simple I_Kr drug block model of G_Kr reduction by 1–50% (250 samples in Figure 1E, F, green) and a complex model of conformation-state dependent I_Kr block in the presence of 2.72 ng/mL dofetilide (300 samples in Figure 1E, F, purple). We combined the drug-free and drugged models with simple and complex I_Kr block model schemes (758 samples) for training the multitask network. The differences in key parameters, upstroke velocity (V_max), maximum diastolic potential (MDP), and action potential durations (APD) across the three conditions are tabulated and shown in Figure 1G.

Figure 1

Download asset Open asset

Next, we applied a digital forward and backward data filtering technique (Gustafsson, 1996) to the simulated iPSC-CM and adult-CM AP traces (Figure 2, left panels). Since we applied physiological noise to introduce a source of variability (as observed in human populations) in our model simulations, we assessed the possible phase distortion for AP waveforms following noise filtering. In Figure 2 (right panels), the distribution of iPSC-CM and adult-CM AP duration at 90% repolarization (APD₉₀) values is shown. The near superimposition of the histogram distributions assures that noise filtering does not change the AP waveform morphology or time course and primarily removes existing vertical noises. Figure 2A, B shows simulated drug-free iPSC-CM and adult-CM APs and corresponding APD₉₀ distribution with physiological noise in blue and after applying the noise filtering technique in black for iPSC-CM APs and red for adult-CM APs. The same plots are illustrated for drugged AP traces with simple 1–50% I_Kr block (Figure 2C, D) and with complex I_Kr block model in the presence of 2.72 ng/mL dofetilide (Figure 2E, F). Next, we normalized drug-free and drugged noise-filtered iPSC-CM APs and adult-CM APs to use them as input and output, respectively, for training the multitask network.

Figure 2

Download asset Open asset

The building blocks of the multitask network are illustrated in Figure 3A. The multitask network receives preprocessed simulation-generated iPSC-CM AP waveforms (noise-filtered and normalized) as input and scans whole AP time-series values through two stacked LSTM layers (Figure 3A, D). The LSTM layers remember the most important iPSC-CM AP values (features) they need to perform the translation and classification tasks and pass the information to two fully connected layers (Figure 3A, E), one for the translation task to predict the corresponding adult-CM AP waveform (Figure 3B) and one for the classification task to classify iPSC-CM APs into drug-free and drugged categories (Figure 3C).

Figure 3

Download asset Open asset

The workflow for training and evaluating the multitask network is depicted in Figure 4. As described above, we generated simulated drug-free and drugged iPSC-CM and adult-CM APs and applied a noise filtering technique to the AP waveforms. The waveforms were then normalized in a data preprocessing step for more efficient training of the multitask network. We used preprocessed iPSC-CM APs as the network input and adult-CM APs along with corresponding drug-free and drugged labels as network outputs, respectively. Next, we randomly split input and output data in 70:10:20 ratio into three subcategories: training, validation, and test datasets. We used the training dataset for training the multitask network to simultaneously perform translation and classification. The mean squared error, R² score (Devore, 2011), and error in adult-CM APD₉₀ prediction were used as evaluation metrics for the translation task. For the classification task, area under the receiver operating characteristic (AUROC) curve (Fawcett, 2006), network prediction accuracy, precision, and recall (Powers, 2011) were used to evaluate the network performance. To prevent overfitting, we calculated the evaluation metrics for both tasks using validation data during each iteration of training and compared those with values from the training dataset. When the model performance on the training dataset exhibited degradation relative to the validation dataset, we ceased training and tuning of the network hyperparameters. We evaluated the underlying mechanisms that inform the network performance by using a holdout test dataset to perform an ablation study. The ablation study allowed us to identify the most important information for network performance and is an indicator of the data that the network deems most important to remember to classify AP traces into drug-free and drugged categories and allow accurate translation into adult-CM APs (feature ablation). Finally, we performed a type of network component dissection by sequentially eliminating individual LSTM layers or the classification task to determine if all elements of the network are important to the overall performance.

Figure 4

Download asset Open asset

Figure 5 and Table 1 illustrate the overall multitask network performance for translation and classification tasks for the training and test datasets. Figure 5A, B represents iPSC-CM APs (black), which were used for training and testing the multitask network, respectively. Figure 5B, E depicts the comparison between simulated (red) and translated (cyan) adult-CM APs used for the training and testing the network. The comparison between histogram distribution of APD₉₀ values for simulated and translated adult-CM APs in Figure 5C, F shows good agreement in terms of the frequency of virtual cells with similar APD.

Figure 5

Download asset Open asset

The performance evaluation metrics for both the translation and classification tasks are listed in Table 1. The multitask network exhibits high accuracy in performing translation, despite large variability in APDs and regardless of the underlying model form. The network is able to translate iPSC-CM APs into adult-CM APs with less than 0.003 mean-squared error (MSE), 0.99 R² score, and <4% error in APD₉₀ prediction for both training and test datasets. To evaluate the network performance for the classification task, we compared the AUROC, prediction accuracy, recall, and precision for both training and test datasets. The multitask network proved to perform well in categorizing iPSC-CM APs into drug-free and drugged waveforms with approximately 90% accuracy (Table 1). Finally, we performed a type of network component dissection by sequentially eliminating individual LSTM layers or the classification task to determine if all elements of the network are important to the overall performance. The impact of removing these elements of the network on the network performance is shown in Table 1.

Next, we performed a ‘computational’ ablation study as a correlate to the types of physiological ablations that are used to examine the roles and functions of a physiological system (LeCun et al., 1989; Reale et al., 1987). We tested how the performance of the multitask network would change by removing various information contained within specified time frames as shown in Figure 6A, B. To reveal the most important iPSC-CM AP information for classifying iPSC-CM APs into drug-free and drugged traces and translation into adult-CM APs, we did not allow the network to process data from within designated time frames from the iPSC-CM APs (feature ablation). We then retrained the multitask network by setting the missing information equal to zero and compared the calculated AUROC for classification task and MSE in adult-CM APs translation (red bars) with the recorded corresponding values for multitask network (green line) when it was provided full access to the complete iPSC-CM AP data. We observed that the network is extremely sensitive to information contained within the 400–500 ms time frame (blacked dashed bar in Figure 6A, B).

Figure 6

Download asset Open asset

This result suggests that the most important information needed to classify iPSC-CM APs into drug-free and drugged traces and distinguish adult-CM AP signals from iPSC-CM AP signals is contained in a particular region of the AP plateau. The time frame of the AP between 400 and 500 ms (Figure 6A, B) corresponds to a phase of exquisite sensitivity to perturbation. We have identified this particular AP range in an earlier study as the phase when the membrane resistance of the myocyte increases markedly (Figure 6C; Yang et al., 2015). This occurs as the inward and outward currents balance each other, leading to a net whole cell current that is nearly constant so that dI → 0, dV/dI → ∞ (Figure 6D), followed by a rapid reduction in outward current. Figure 6E demonstrates that individual current densities have a period of inward and outward current balance followed by rapid changes in I_Kr and other repolarizing currents at 400–500 ms time interval.

We next set out to demonstrate the real-world utility of the multitask classification and translation network by applying the network to experimental data. We used experimental iPSC-CM APs from the Kurokawa lab (Figure 7A) as the input data into the multitask network and translated to predicted adult-CM APs as shown in Figure 7B. The translation notably resulted in a reduction in variability in APD in the adult translated cells, consistent with our simulated results and with previous experimental observations (Blinova et al., 2018; Fabbri et al., 2019). In an additional validation of the multitask network, we undertook a test of the network to accurately translate drug block in iPSC-CMs to adult AP effects and then compared the predicted results with measured experimental data (O'Hara et al., 2011). We first simulated iPSC-CM APs with 50% block of I_Kr. We then used these simulated APs as an input for the multitask network and used the output from the translation task to predict 50% block on adult-CMs. In Figure 7C, the translated drugged APD₉₀ values are shown as turquoise asterisks from spontaneously beating (~1000 ms cycle length) simulated iPSC-CMs plotted against simulations from O’Hara–Rudy adult-CM APs with 50% I_Kr block (red curve) and experimental 50% block of I_Kr by 1 μM E-4031 (blue squares) (O'Hara et al., 2011). These data validate that the effects of drug block in iPSC-CMs can be successfully translated to predict drug effect on adult human cardiomyocyte APs.

Figure 7

Download asset Open asset

In this study, we developed a data-driven deep learning approach to address the well-known shortcomings in the iPSC-CM platform. A concern with iPSC-CM is that the data collection results in measurements from immature APs, and it is unclear if these data reliably indicate impact in the adult cardiac environment (Navarrete et al., 2013; Casini et al., 2017; Goversen et al., 2018; Knollmann, 2013; Sinnecker et al., 2013; Blinova et al., 2017). Here, we set out to demonstrate a new way to allow translation of results from the iPSC-CM to a mature adult cardiac response. The deep learning network also revealed new mechanisms that are critical to convert iPSC-CM APs to mature adult cardiac APs.

Application of a deep learning ANN to simultaneously translate and classify signals from simulated iPSC-CMs for both drug-free and drugged conditions has several key advantages. Because there is no need for the multitask network user to a priori define the important system parameters, the approach is by definition an unbiased model. A key part of the ‘artificial intelligence’ is learning from the data to make decisions about which elements of the data are the most important. Another benefit is the model-agnostic approach in that the learning network is indifferent to the underlying form of the models and can readily translate time-series data from any source. The nonlinearity of the system is accepted by the deep learning approach, and there are no assumptions made about cardiac protein expression levels and changes in their function during cardiomyocyte maturation. The deep learning ANN can successfully translate simple pore block and complex conformation state-dependent channel–drug interaction models. The network can learn from multiple sources of data even when they are generated from different models and learns from all the data sources concurrently for robust and successful translation. All of these aspects of the technology presented here suggest broad applicability for use across ages, species, and conditions, and we demonstrate its utility for translating and predicting experimental data.

The multitask network presented here performed well in the setting of the noted variability in measurements from iPSC-CM APs. As described in Figure 1, we utilized a modeling and simulation approach from our recent studies (Kernik et al., 2019; Kernik et al., 2020) to generate a population of iPSC-CM APs that incorporate variability comparable to that in experimental measurements. Utilizing simulated data presented a unique opportunity: we were able to generate large amounts of data that were used both to train and optimize the network and then to test the network with specifically designated distinct simulated datasets. Utilizing simulated data to train a deep learning network may constitute a widely applicable approach that could be used to train a variety of networks to perform multiple functions where access to comparable experimental data is not feasible.

The multitask network exhibits high accuracy in performing translation, despite large variability in APDs and regardless of the underlying model form (Figure 5 and Table 1). The network was able to translate iPSC-CM APs into adult-CM APs with less than 0.003 MSE, 0.99 R² score, and less than 4% error in APD₉₀ prediction for both the training and test datasets. To evaluate the network performance for the classification task, we compared the AUROC, prediction accuracy, recall, and precision for both training and test datasets. The multitask network proved to perform well in categorizing iPSC-CM APs into drug-free and drugged waveforms with approximately 90% accuracy (Table 1). Finally, we performed a type of network component dissection by sequentially eliminated individual LSTM layers or the classification task to determine if all elements of the network are important to the overall performance. The impact of removing these elements of the network on its performance is shown in Table 1. The studies show that the multitask network conferred additional benefit over considering the translation task alone. For example, we noted that adding the classification task to distinguish drug-free and drugged APs could improve the performance of the translation task (Table 1).

When we performed an ablation study to prevent the deep learning network from using information within prespecified time windows, the results revealed that the most important information needed to classify iPSC-CM APs into drug-free and drugged traces and predict adult-CM APs from iPSC-CM AP signals is contained in the phase of the AP between 400 and 500 ms (Figure 6). This result suggests that the most important information needed to classify and distinguish iPSC-CM AP signals from adult-CM AP signals is contained in the range of the AP that corresponds to a phase of exquisite sensitivity to perturbation. We have identified this particular AP range in an earlier study as the phase when the membrane resistance of the myocyte increases markedly (Figure 6C; Yang et al., 2015). This occurs as the inward and outward currents balance each other, leading to a net whole cell current that is unchanging (dI → 0, dV/dI → ∞), followed by a rapid reduction in the outward current (Figure 6D, E). It is not surprising that this time frame is shown to contain the most important information to perform the classification task as the effect of I_Kr block is critical during the high resistance phase of the membrane potential. It is possible that other types of perturbations (e.g., Na channel blocker, ischemia) may lead to a different outcome, and we will pursue those questions in future studies.

Following the optimization and demonstration of the network as an accurate tool for both translating and classifying data, we then used the same network to translate experimentally obtained data. We showed that the proposed network can effectively take experimental data as an input from immature iPSC-CM APs and translate those data to produce adult AP waveforms. It is notable that the variation observed in the adult-CM AP duration is smaller compared to iPSC-CM APDs (Figure 7A, B). This has been observed both experimentally (Blinova et al., 2018; Fabbri et al., 2019) and in our simulated cell environment (Kernik et al., 2019; Kernik et al., 2020). Although the simulated iPSC-CM has a large initial calcium current (Figure 1C) compared to the simulated adult-CM (Figure 1D), the amplitude of currents flowing through adult-CM AP plateau is notably larger. The immature iPSC-CM cells have low conductance during the AP plateau, rendering it comparably higher resistance. For this reason, small perturbations to the iPSC-CM APs have a larger impact on the resulting AP duration than observed in adult cells (Yang et al., 2015). We also used simulated iPSC-CM APs subject to 50% block of I_Kr. We translated those data to adult-CM APs and then compared with the previously reported impact of 50% I_Kr block on adult human cell APs from experiments (O'Hara et al., 2011) and noted excellent agreement, thereby providing validation of our network.

The deep learning algorithm presented here has the benefit of automating feature extraction without any predetermination of the feature. It also allows for the translation of time-course data from simulated or experimental datasets. However, there are some limitations to the approach. One limitation is the requirement for multiple datasets that are of sufficient quality for training – the more robust the training set, the higher the accuracy of the task. It is possible that this limitation can be addressed in future studies by developing new methods for data extraction and data interpolation in sparse datasets. We addressed this limitation by utilizing simulated data to train the network, and this approach might be applicable for a variety of physiological problems. Simulated data can be generated to constitute a robust dataset that can be used to train the multitask model and allow extraction of the relevant features from any time-course dataset.

In this study, we show that a deep learning network can be applied to classify cells into the drug-free and drugged categories and can be used to predict the impact of electrophysiological perturbation across the continuum of aging from the immature iPSC-CM AP to the adult ventricular myocyte AP. By extension, the classification task might even be applied to distinguish cellular-level signals derived from cells cultured using different protocols. We translated experimental immature APs into mature APs using the proposed network and validated the output of some key model simulations with experimental data. The multitask network in this study was used for translation of iPSC-CMs to adult APs but could be readily extended and applied to translate data across species and classify data from a variety of systems. Also, another extension of the technology presented here is to predict the impact of naturally occurring mutations and other genetic variations (Yoshinaga et al., 2019).

Since we used simulated data, we have made all drugged and drug-free iPSC-CM and adult-CM AP data used for training and testing the multitask network publicly available at Clancy lab Github. (https://github.com/ClancyLabUCD/Multitask_network/tree/master/data, copy archived at https://archive.softwareheritage.org/swh:1:rev:7f2b653a91f552d66ae2d9b70b720f8706b36da3). In addition, we have illustrated training and test dataset in Figure 1 and Figure 5. We have also shared the jupyter notebook for preparing clean and organized data for training the network at Clancy lab Github (https://github.com/ClancyLabUCD/Multitask_network/tree/master/jupyter). We also made experimental data used for the model validation publicly available at Clancy lab Github. (https://github.com/ClancyLabUCD/Multitask_network/blob/master/data/clean_data/experiments.csv ). Figure 7 illustrates the experimental data we used to validate the network.

1. Software

   1. Aghasafari P

   (2021) Multitask-network, version 7f2b653

   GitHub.

   https://github.com/ClancyLabUCD/Multitask_network
2. 1. Alhusseini MI
   2. Abuzaid F
   3. Rogers AJ
   4. Zaman JAB
   5. Baykaner T
   6. Clopton P
   7. Bailis P
   8. Zaharia M
   9. Wang PJ
   10. Rappel WJ
   11. Narayan SM

   (2020) Machine learning to classify intracardiac electrical patterns during atrial fibrillation: machine learning of atrial fibrillation

   Circulation. Arrhythmia and Electrophysiology 13:e008160.

   https://doi.org/10.1161/CIRCEP.119.008160

   • PubMed
   • Google Scholar
3. Book

   1. Atkinson KE

   (2008)

   An Introduction to Numerical Analysis

   John wiley & sons.

   • Google Scholar
4. Conference

   1. Ballinger B

   (2018)

   DeepHeart: semi-supervised sequence learning for cardiovascular risk prediction

   In Thirty-Second AAAI Conference On Artificial Intelligence.

   • Google Scholar
5. Conference

   1. Bian M

   (2019)

   An accurate lstm based video heart rate estimation method

   In Chinese Conference on Pattern Recognition and Computer Vision (PRCV).

   • Google Scholar
6. 1. Blinova K
   2. Stohlman J
   3. Vicente J
   4. Chan D
   5. Johannesen L
   6. Hortigon-Vinagre MP
   7. Zamora V
   8. Smith G
   9. Crumb WJ
   10. Pang L
   11. Lyn-Cook B
   12. Ross J
   13. Brock M
   14. Chvatal S
   15. Millard D
   16. Galeotti L
   17. Stockbridge N
   18. Strauss DG

   (2017) Comprehensive translational assessment of Human-Induced pluripotent stem cell derived cardiomyocytes for evaluating Drug-Induced arrhythmias

   Toxicological Sciences 155:234–247.

   https://doi.org/10.1093/toxsci/kfw200

   • PubMed
   • Google Scholar
7. 1. Blinova K
   2. Dang Q
   3. Millard D
   4. Smith G
   5. Pierson J
   6. Guo L
   7. Brock M
   8. Lu HR
   9. Kraushaar U
   10. Zeng H
   11. Shi H
   12. Zhang X
   13. Sawada K
   14. Osada T
   15. Kanda Y
   16. Sekino Y
   17. Pang L
   18. Feaster TK
   19. Kettenhofen R
   20. Stockbridge N
   21. Strauss DG
   22. Gintant G

   (2018) International multisite study of Human-Induced pluripotent stem Cell-Derived cardiomyocytes for drug proarrhythmic potential assessment

   Cell Reports 24:3582–3592.

   https://doi.org/10.1016/j.celrep.2018.08.079

   • PubMed
   • Google Scholar
8. 1. Burridge PW
   2. Li YF
   3. Matsa E
   4. Wu H
   5. Ong SG
   6. Sharma A
   7. Holmström A
   8. Chang AC
   9. Coronado MJ
   10. Ebert AD
   11. Knowles JW
   12. Telli ML
   13. Witteles RM
   14. Blau HM
   15. Bernstein D
   16. Altman RB
   17. Wu JC

   (2016) Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast Cancer patients to doxorubicin-induced cardiotoxicity

   Nature Medicine 22:547–556.

   https://doi.org/10.1038/nm.4087

   • PubMed
   • Google Scholar
9. 1. Cai C
   2. Guo P
   3. Zhou Y
   4. Zhou J
   5. Wang Q
   6. Zhang F
   7. Fang J
   8. Cheng F

   (2019) Deep Learning-Based prediction of Drug-Induced cardiotoxicity

   Journal of Chemical Information and Modeling 59:1073–1084.

   https://doi.org/10.1021/acs.jcim.8b00769

   • PubMed
   • Google Scholar
10. Book

    1. Carugo O
    2. Eisenhaber F

    (2010) Data Mining Techniques for the Life Sciences

    Springer.

    https://doi.org/10.1007/978-1-60327-241-4

    • Google Scholar
11. 1. Casini S
    2. Verkerk AO
    3. Remme CA

    (2017) Human iPSC-Derived cardiomyocytes for investigation of disease mechanisms and therapeutic strategies in inherited arrhythmia syndromes: strengths and limitations

    Cardiovascular Drugs and Therapy 31:325–344.

    https://doi.org/10.1007/s10557-017-6735-0

    • PubMed
    • Google Scholar
12. 1. Chen C
    2. Hua Z
    3. Zhang R
    4. Liu G
    5. Wen W

    (2020) Automated arrhythmia classification based on a combination network of CNN and LSTM

    Biomedical Signal Processing and Control 57:101819.

    https://doi.org/10.1016/j.bspc.2019.101819

    • Google Scholar
13. Preprint

    1. Cheng J
    2. Dong L
    3. Lapata M

    (2016) Long short-term memory-networks for machine reading

    arXiv.

    https://arxiv.org/abs/1601.06733

    • Google Scholar
14. 1. Collins TA
    2. Rolf MG
    3. Pointon A

    (2020) Current and future approaches to nonclinical cardiovascular safety assessment

    Drug Discovery Today 25:1129–1134.

    https://doi.org/10.1016/j.drudis.2020.03.011

    • PubMed
    • Google Scholar
15. 1. de Korte T
    2. Katili PA
    3. Mohd Yusof NAN
    4. van Meer BJ
    5. Saleem U
    6. Burton FL
    7. Smith GL
    8. Clements P
    9. Mummery CL
    10. Eschenhagen T
    11. Hansen A
    12. Denning C

    (2020) Unlocking personalized biomedicine and drug discovery with human induced pluripotent stem Cell-Derived cardiomyocytes: fit for purpose or forever elusive?

    Annual Review of Pharmacology and Toxicology 60:529–551.

    https://doi.org/10.1146/annurev-pharmtox-010919-023309

    • PubMed
    • Google Scholar
16. Book

    1. Devore JL

    (2011)

    Probability and Statistics for Engineering and the Sciences

    Cengage learning.

    • Google Scholar
17. 1. Dickson CJ
    2. Velez-Vega C
    3. Duca JS

    (2020) Revealing molecular determinants of hERG blocker and activator binding

    Journal of Chemical Information and Modeling 60:192–203.

    https://doi.org/10.1021/acs.jcim.9b00773

    • PubMed
    • Google Scholar
18. 1. Doss MX
    2. Sachinidis A

    (2019) Current challenges of iPSC-Based disease modeling and therapeutic implications

    Cells 8:403.

    https://doi.org/10.3390/cells8050403

    • Google Scholar
19. 1. Fabbri A
    2. Goversen B
    3. Vos MA
    4. van Veen TAB
    5. de Boer TP

    (2019) Required G_K1 to suppress automaticity of iPSC-CMs depends strongly on I_K1 Model Structure

    Biophysical Journal 117:2303–2315.

    https://doi.org/10.1016/j.bpj.2019.08.040

    • PubMed
    • Google Scholar
20. 1. Fawcett T

    (2006) An introduction to ROC analysis

    Pattern Recognition Letters 27:861–874.

    https://doi.org/10.1016/j.patrec.2005.10.010

    • Google Scholar
21. Conference

    1. Glorot X
    2. Bordes A
    3. Bengio Y

    (2011)

    Deep sparse rectifier neural networks JMLR Workshop and Conference Proceedings

    In Proceedings of The Fourteenth International Conference on Artificial Intelligence and Statistics.

    • Google Scholar
22. 1. Gong JQX
    2. Sobie EA

    (2018) Population-based mechanistic modeling allows for quantitative predictions of drug responses across cell types

    Npj Systems Biology and Applications 4:1–11.

    https://doi.org/10.1038/s41540-018-0047-2

    • PubMed
    • Google Scholar
23. Book

    1. Goodfellow I
    2. Bengio Y
    3. Courville A

    (2016)

    Deep Learning

    MIT press.

    • Google Scholar
24. 1. Goversen B
    2. van der Heyden MAG
    3. van Veen TAB
    4. de Boer TP

    (2018) The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on I_K1

    Pharmacology & Therapeutics 183:127–136.

    https://doi.org/10.1016/j.pharmthera.2017.10.001

    • PubMed
    • Google Scholar
25. 1. Guo A
    2. Beheshti R
    3. Khan YM
    4. Langabeer JR
    5. Foraker RE

    (2021) Predicting cardiovascular health trajectories in time-series electronic health records with LSTM models

    BMC Medical Informatics and Decision Making 21:1–10.

    https://doi.org/10.1186/s12911-020-01345-1

    • PubMed
    • Google Scholar
26. 1. Gustafsson F

    (1996) Determining the initial states in forward-backward filtering

    IEEE Transactions on Signal Processing 44:988–992.

    https://doi.org/10.1109/78.492552

    • Google Scholar
27. 1. He R
    2. Liu Y
    3. Wang K
    4. Zhao N
    5. Yuan Y
    6. Li Q
    7. Zhang H

    (2019) Automatic cardiac arrhythmia classification using combination of deep residual network and bidirectional LSTM

    IEEE Access 7:102119–102135.

    https://doi.org/10.1109/ACCESS.2019.2931500

    • Google Scholar
28. 1. Hochreiter S
    2. Schmidhuber J

    (1997) Long short-term memory

    Neural Computation 9:1735–1780.

    https://doi.org/10.1162/neco.1997.9.8.1735

    • PubMed
    • Google Scholar
29. 1. Hou B
    2. Yang J
    3. Wang P
    4. Yan R

    (2019) LSTM-Based Auto-Encoder model for ECG arrhythmias classification

    IEEE Transactions on Instrumentation and Measurement 69:1232–1240.

    https://doi.org/10.1109/TIM.2019.2910342

    • Google Scholar
30. Conference

    1. Jin Z
    2. Oresko J
    3. Huang S
    4. Cheng AC

    (2009) HeartToGo: a personalized medicine technology for cardiovascular disease prevention and detection

    IEEE/NIH Life Science Systems and Applications Workshop.

    https://doi.org/10.1109/LISSA.2009.4906714

    • Google Scholar
31. 1. Kernik DC
    2. Morotti S
    3. Wu H
    4. Garg P
    5. Duff HJ
    6. Kurokawa J
    7. Jalife J
    8. Wu JC
    9. Grandi E
    10. Clancy CE

    (2019) A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources

    The Journal of Physiology 597:4533–4564.

    https://doi.org/10.1113/JP277724

    • PubMed
    • Google Scholar
32. 1. Kernik DC
    2. Yang PC
    3. Kurokawa J
    4. Wu JC
    5. Clancy CE

    (2020) A computational model of induced pluripotent stem-cell derived cardiomyocytes for high throughput risk stratification of KCNQ1 genetic variants

    PLOS Computational Biology 16:e1008109.

    https://doi.org/10.1371/journal.pcbi.1008109

    • PubMed
    • Google Scholar
33. Book

    1. Ketkar N

    (2017) Introduction to pytorch

    In: Chollet François, editors.  Deep Learning with Python. Springer. pp. 195–208.

    https://doi.org/10.1007/978-1-4842-2766-4

    • Google Scholar
34. Preprint

    1. Kingma DP
    2. Ba J

    (2014) Adam: a method for stochastic optimization

    arXiv.

    https://arxiv.org/abs/1412.6980

    • Google Scholar
35. 1. Knollmann BC

    (2013) Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?

    Circulation Research 112:969–976.

    https://doi.org/10.1161/CIRCRESAHA.112.300567

    • PubMed
    • Google Scholar
36. 1. Koivumäki JT
    2. Naumenko N
    3. Tuomainen T
    4. Takalo J
    5. Oksanen M
    6. Puttonen KA
    7. Lehtonen Š
    8. Kuusisto J
    9. Laakso M
    10. Koistinaho J
    11. Tavi P

    (2018) Structural immaturity of human iPSC-Derived cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling

    Frontiers in Physiology 9:80.

    https://doi.org/10.3389/fphys.2018.00080

    • PubMed
    • Google Scholar
37. 1. Krogh A

    (2008) What are artificial neural networks?

    Nature Biotechnology 26:195–197.

    https://doi.org/10.1038/nbt1386

    • PubMed
    • Google Scholar
38. 1. Lan F
    2. Lee AS
    3. Liang P
    4. Sanchez-Freire V
    5. Nguyen PK
    6. Wang L
    7. Han L
    8. Yen M
    9. Wang Y
    10. Sun N
    11. Abilez OJ
    12. Hu S
    13. Ebert AD
    14. Navarrete EG
    15. Simmons CS
    16. Wheeler M
    17. Pruitt B
    18. Lewis R
    19. Yamaguchi Y
    20. Ashley EA
    21. Bers DM
    22. Robbins RC
    23. Longaker MT
    24. Wu JC

    (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells

    Cell Stem Cell 12:101–113.

    https://doi.org/10.1016/j.stem.2012.10.010

    • PubMed
    • Google Scholar
39. Conference

    1. LeCun Y
    2. Denker J
    3. Solla S

    (1989)

    Optimal brain damage

    Advances in Neural Information Processing Systems. pp. 598–605.

    • Google Scholar
40. 1. Leyton-Mange JS
    2. Mills RW
    3. Macri VS
    4. Jang MY
    5. Butte FN
    6. Ellinor PT
    7. Milan DJ

    (2014) Rapid cellular phenotyping of human pluripotent stem cell-derived cardiomyocytes using a genetically encoded fluorescent voltage sensor

    Stem Cell Reports 2:163–170.

    https://doi.org/10.1016/j.stemcr.2014.01.003

    • PubMed
    • Google Scholar
41. 1. Li M
    2. Kanda Y
    3. Ashihara T
    4. Sasano T
    5. Nakai Y
    6. Kodama M
    7. Hayashi E
    8. Sekino Y
    9. Furukawa T
    10. Kurokawa J

    (2017) Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs

    Journal of Pharmacological Sciences 134:75–85.

    https://doi.org/10.1016/j.jphs.2017.05.004

    • PubMed
    • Google Scholar
42. 1. Li Z
    2. Mirams GR
    3. Yoshinaga T
    4. Ridder BJ
    5. Han X
    6. Chen JE
    7. Stockbridge NL
    8. Wisialowski TA
    9. Damiano B
    10. Severi S
    11. Morissette P
    12. Kowey PR
    13. Holbrook M
    14. Smith G
    15. Rasmusson RL
    16. Liu M
    17. Song Z
    18. Qu Z
    19. Leishman DJ
    20. Steidl-Nichols J
    21. Rodriguez B
    22. Bueno-Orovio A
    23. Zhou X
    24. Passini E
    25. Edwards AG
    26. Morotti S
    27. Ni H
    28. Grandi E
    29. Clancy CE
    30. Vandenberg J
    31. Hill A
    32. Nakamura M
    33. Singer T
    34. Polonchuk L
    35. Greiter-Wilke A
    36. Wang K
    37. Nave S
    38. Fullerton A
    39. Sobie EA
    40. Paci M
    41. Musuamba Tshinanu F
    42. Strauss DG

    (2020) General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy

    Clinical Pharmacology & Therapeutics 107:102–111.

    https://doi.org/10.1002/cpt.1647

    • PubMed
    • Google Scholar
43. 1. Lieu DK
    2. Fu JD
    3. Chiamvimonvat N
    4. Tung KC
    5. McNerney GP
    6. Huser T
    7. Keller G
    8. Kong CW
    9. Li RA

    (2013) Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes

    Circulation: Arrhythmia and Electrophysiology 6:191–201.

    https://doi.org/10.1161/CIRCEP.111.973420

    • PubMed
    • Google Scholar
44. Conference

    1. Liu F
    2. Zhou X
    3. Cao J
    4. Wang Z
    5. Wang H
    6. Zhang Y

    (2019) A LSTM and CNN based assemble neural network framework for arrhythmias classification

    In ICASSP 2019-2019 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP).

    https://doi.org/10.1109/ICASSP.2019.8682299

    • Google Scholar
45. 1. Maragatham G
    2. Devi S

    (2019) LSTM model for prediction of heart failure in big data

    Journal of Medical Systems 43:1–13.

    https://doi.org/10.1007/s10916-019-1243-3

    • Google Scholar
46. 1. Martis RJ
    2. Acharya UR
    3. Lim CM
    4. Mandana KM
    5. Ray AK
    6. Chakraborty C

    (2013) Application of higher order cumulant features for cardiac health diagnosis using ECG signals

    International Journal of Neural Systems 23:1350014.

    https://doi.org/10.1142/S0129065713500147

    • PubMed
    • Google Scholar
47. 1. Matsa E
    2. Ahrens JH
    3. Wu JC

    (2016) Human induced pluripotent stem cells as a platform for personalized and precision cardiovascular medicine

    Physiological Reviews 96:1093–1126.

    https://doi.org/10.1152/physrev.00036.2015

    • PubMed
    • Google Scholar
48. Book

    1. Murphy KP

    (2012)

    Machine Learning: A Probabilistic Perspective

    MIT press.

    • Google Scholar
49. 1. Navarrete EG
    2. Liang P
    3. Lan F
    4. Sanchez-Freire V
    5. Simmons C
    6. Gong T
    7. Sharma A
    8. Burridge PW
    9. Patlolla B
    10. Lee AS
    11. Wu H
    12. Beygui RE
    13. Wu SM
    14. Robbins RC
    15. Bers DM
    16. Wu JC

    (2013) Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays

    Circulation 128:S3–S13.

    https://doi.org/10.1161/CIRCULATIONAHA.112.000570

    • PubMed
    • Google Scholar
50. 1. O'Hara T
    2. Virág L
    3. Varró A
    4. Rudy Y

    (2011) Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation

    PLOS Computational Biology 7:e1002061.

    https://doi.org/10.1371/journal.pcbi.1002061

    • PubMed
    • Google Scholar
51. 1. Oh SL
    2. Ng EYK
    3. Tan RS
    4. Acharya UR

    (2018) Automated diagnosis of arrhythmia using combination of CNN and LSTM techniques with variable length heart beats

    Computers in Biology and Medicine 102:278–287.

    https://doi.org/10.1016/j.compbiomed.2018.06.002

    • PubMed
    • Google Scholar
52. Software

    1. Olah C

    (2017) Understanding LSTM Networks. Aug. 2015, version LSTMs

    Github.

    https://colah.github.io/posts/2015-08-Understanding-LSTMs
53. 1. Picon A
    2. Irusta U
    3. Álvarez-Gila A
    4. Aramendi E
    5. Alonso-Atienza F
    6. Figuera C
    7. Ayala U
    8. Garrote E
    9. Wik L
    10. Kramer-Johansen J
    11. Eftestøl T

    (2019) Mixed convolutional and long short-term memory network for the detection of lethal ventricular arrhythmia

    PLOS ONE 14:e0216756.

    https://doi.org/10.1371/journal.pone.0216756

    • PubMed
    • Google Scholar
54. Preprint

    1. Powers DM

    (2011) Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation

    arXiv.

    https://arxiv.org/abs/2010.16061

    • Google Scholar
55. 1. Reale RA
    2. Brugge JF
    3. Chan JCK

    (1987) Maps of auditory cortex in cats reared after unilateral cochlear ablation in the neonatal period

    Developmental Brain Research 34:281–290.

    https://doi.org/10.1016/0165-3806(87)90215-X

    • Google Scholar
56. 1. Rogers AJ

    (2020) Machine learned cellular phenotypes predict outcome in ischemic cardiomyopathy

    Circulation Research 128:172–184.

    https://doi.org/10.1161/CIRCRESAHA.120.317345

    • Google Scholar
57. 1. Ryu JY
    2. Lee MY
    3. Lee JH
    4. Lee BH
    5. Oh KS

    (2020) DeepHIT: a deep learning framework for prediction of hERG-induced cardiotoxicity

    Bioinformatics 36:3049–3055.

    https://doi.org/10.1093/bioinformatics/btaa075

    • PubMed
    • Google Scholar
58. 1. Sala L
    2. Bellin M
    3. Mummery CL

    (2017) Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

    British Journal of Pharmacology 174:3749–3765.

    https://doi.org/10.1111/bph.13577

    • PubMed
    • Google Scholar
59. 1. Sayed N
    2. Liu C
    3. Wu JC

    (2016) Translation of Human-Induced pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine

    Journal of the American College of Cardiology 67:2161–2176.

    https://doi.org/10.1016/j.jacc.2016.01.083

    • PubMed
    • Google Scholar
60. 1. Sevakula RK
    2. Au-Yeung WM
    3. Singh JP
    4. Heist EK
    5. Isselbacher EM
    6. Armoundas AA

    (2020) State-of-the-Art machine learning techniques aiming to improve patient outcomes pertaining to the cardiovascular system

    Journal of the American Heart Association 9:e013924.

    https://doi.org/10.1161/JAHA.119.013924

    • PubMed
    • Google Scholar
61. 1. Shaheen N
    2. Shiti A
    3. Huber I
    4. Shinnawi R
    5. Arbel G
    6. Gepstein A
    7. Setter N
    8. Goldfracht I
    9. Gruber A
    10. Chorna SV
    11. Gepstein L

    (2018) Human induced pluripotent stem Cell-Derived cardiac cell sheets expressing genetically encoded voltage Indicator for pharmacological and arrhythmia studies

    Stem Cell Reports 10:1879–1894.

    https://doi.org/10.1016/j.stemcr.2018.04.006

    • PubMed
    • Google Scholar
62. 1. Shi K
    2. Steigleder T
    3. Schellenberger S
    4. Michler F
    5. Malessa A
    6. Lurz F
    7. Rohleder N
    8. Ostgathe C
    9. Weigel R
    10. Koelpin A

    (2021) Contactless analysis of heart rate variability during cold pressor test using radar interferometry and bidirectional LSTM networks

    Scientific Reports 11:1–13.

    https://doi.org/10.1038/s41598-021-81101-1

    • Google Scholar
63. 1. Sinnecker D
    2. Goedel A
    3. Laugwitz KL
    4. Moretti A

    (2013) Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research

    Circulation Research 112:961–968.

    https://doi.org/10.1161/CIRCRESAHA.112.268623

    • PubMed
    • Google Scholar
64. 1. Sube R
    2. Ertel EA

    (2017) Cardiomyocytes derived from human induced pluripotent stem cells: an In-Vitro model to predict cardiac effects of drugs

    Journal of Biomedical Science and Engineering 10:527–549.

    https://doi.org/10.4236/jbise.2017.1011040

    • Google Scholar
65. 1. Sun N
    2. Yazawa M
    3. Liu J
    4. Han L
    5. Sanchez-Freire V
    6. Abilez OJ
    7. Navarrete EG
    8. Hu S
    9. Wang L
    10. Lee A
    11. Pavlovic A
    12. Lin S
    13. Chen R
    14. Hajjar RJ
    15. Snyder MP
    16. Dolmetsch RE
    17. Butte MJ
    18. Ashley EA
    19. Longaker MT
    20. Robbins RC
    21. Wu JC

    (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy

    Science Translational Medicine 4:130ra47.

    https://doi.org/10.1126/scitranslmed.3003552

    • PubMed
    • Google Scholar
66. 1. Tanskanen AJ
    2. Alvarez LH

    (2007) Voltage noise influences action potential duration in cardiac myocytes

    Mathematical Biosciences 208:125–146.

    https://doi.org/10.1016/j.mbs.2006.09.023

    • PubMed
    • Google Scholar
67. 1. Trayanova NA
    2. Popescu DM
    3. Shade JK

    (2021) Machine learning in arrhythmia and electrophysiology

    Circulation Research 128:544–566.

    https://doi.org/10.1161/CIRCRESAHA.120.317872

    • PubMed
    • Google Scholar
68. 1. Tu C
    2. Chao BS
    3. Wu JC

    (2018) Strategies for improving the maturity of human induced pluripotent stem Cell-Derived cardiomyocytes

    Circulation Research 123:512–514.

    https://doi.org/10.1161/CIRCRESAHA.118.313472

    • PubMed
    • Google Scholar
69. 1. Tveito A
    2. Jæger KH
    3. Huebsch N
    4. Charrez B
    5. Edwards AG
    6. Wall S
    7. Healy KE

    (2018) Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems

    Scientific Reports 8:1–14.

    https://doi.org/10.1038/s41598-018-35858-7

    • PubMed
    • Google Scholar
70. 1. Tveito A
    2. Jæger KH
    3. Maleckar MM
    4. Giles WR
    5. Wall S

    (2020) Computational translation of drug effects from animal experiments to human ventricular myocytes

    Scientific Reports 10:1–11.

    https://doi.org/10.1038/s41598-020-66910-0

    • PubMed
    • Google Scholar
71. 1. Veerman CC
    2. Kosmidis G
    3. Mummery CL
    4. Casini S
    5. Verkerk AO
    6. Bellin M

    (2015) Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?

    Stem Cells and Development 24:1035–1052.

    https://doi.org/10.1089/scd.2014.0533

    • PubMed
    • Google Scholar
72. 1. Wang EK
    2. Zhang X
    3. Pan L

    (2019) Automatic classification of CAD ECG signals with SDAE and bidirectional long Short-Term network

    IEEE Access 7:182873–182880.

    https://doi.org/10.1109/ACCESS.2019.2936525

    • Google Scholar
73. 1. Wang L
    2. Zhou X

    (2019) Detection of congestive heart failure based on LSTM-Based deep network via Short-Term RR intervals

    Sensors 19:1502.

    https://doi.org/10.3390/s19071502

    • Google Scholar
74. Conference

    1. Warrick P
    2. Homsi MN

    (2017)

    Cardiac arrhythmia detection from ECG combining convolutional and long short-term memory networks

    In 2017 Computing in Cardiology (CinC).

    • Google Scholar
75. 1. Wu JC
    2. Garg P
    3. Yoshida Y
    4. Yamanaka S
    5. Gepstein L
    6. Hulot JS
    7. Knollmann BC
    8. Schwartz PJ

    (2019) Towards precision medicine with human iPSCs for cardiac channelopathies

    Circulation Research 125:653–658.

    https://doi.org/10.1161/CIRCRESAHA.119.315209

    • PubMed
    • Google Scholar
76. 1. Yang PC
    2. Song Y
    3. Giles WR
    4. Horvath B
    5. Chen-Izu Y
    6. Belardinelli L
    7. Rajamani S
    8. Clancy CE

    (2015) A computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late na+ current

    The Journal of Physiology 593:1429–1442.

    https://doi.org/10.1113/jphysiol.2014.279554

    • PubMed
    • Google Scholar
77. 1. Yang PC
    2. DeMarco KR
    3. Aghasafari P
    4. Jeng MT
    5. Dawson JRD
    6. Bekker S
    7. Noskov SY
    8. Yarov-Yarovoy V
    9. Vorobyov I
    10. Clancy CE

    (2020) A computational pipeline to predict cardiotoxicity: from the atom to the rhythm

    Circulation Research 126:947–964.

    https://doi.org/10.1161/CIRCRESAHA.119.316404

    • PubMed
    • Google Scholar
78. 1. Yildirim Ö

    (2018) A novel wavelet sequence based on deep bidirectional LSTM network model for ECG signal classification

    Computers in Biology and Medicine 96:189–202.

    https://doi.org/10.1016/j.compbiomed.2018.03.016

    • PubMed
    • Google Scholar
79. 1. Yildirim O
    2. Baloglu UB
    3. Tan RS
    4. Ciaccio EJ
    5. Acharya UR

    (2019) A new approach for arrhythmia classification using deep coded features and LSTM networks

    Computer Methods and Programs in Biomedicine 176:121–133.

    https://doi.org/10.1016/j.cmpb.2019.05.004

    • PubMed
    • Google Scholar
80. 1. Yoshinaga D
    2. Baba S
    3. Makiyama T
    4. Shibata H
    5. Hirata T
    6. Akagi K
    7. Matsuda K
    8. Kohjitani H
    9. Wuriyanghai Y
    10. Umeda K
    11. Yamamoto Y
    12. Conklin BR
    13. Horie M
    14. Takita J
    15. Heike T

    (2019) Phenotype-Based High-Throughput classification of long QT syndrome subtypes using human induced pluripotent stem cells

    Stem Cell Reports 13:394–404.

    https://doi.org/10.1016/j.stemcr.2019.06.007

    • PubMed
    • Google Scholar
81. Preprint

    1. Zaremba W
    2. Sutskever I
    3. Vinyals O

    (2014) Recurrent neural network regularization

    arXiv.

    https://arxiv.org/abs/1409.2329

    • Google Scholar
82. 1. Zhang Y
    2. Zhao J
    3. Wang Y
    4. Fan Y
    5. Zhu L
    6. Yang Y
    7. Chen X
    8. Lu T
    9. Chen Y
    10. Liu H

    (2019) Prediction of hERG K+ channel blockage using deep neural networks

    Chemical Biology & Drug Design 94:1973–1985.

    https://doi.org/10.1111/cbdd.13600

    • PubMed
    • Google Scholar

Author details

1. Parya Aghasafari

   Department of Physiology and Membrane Biology, University of California, Davis, Davis, United States

   Contribution

   Conceptualization, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing

   Competing interests

   No competing interests declared

2. Pei-Chi Yang

   Department of Physiology and Membrane Biology, University of California, Davis, Davis, United States

   Contribution

   Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing

   Competing interests

   No competing interests declared

3. Divya C Kernik

   Washington University in St. Louis, St. Louis, United States

   Contribution

   Data curation, Methodology, Writing - original draft

   Competing interests

   No competing interests declared

4. Kazuho Sakamoto

   Department of Bio-Informational Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

   Contribution

   Data curation, Validation

   Competing interests

   No competing interests declared

5. Yasunari Kanda

   Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan

   Contribution

   Data curation, Validation

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-2527-3526

6. Junko Kurokawa

   Department of Bio-Informational Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

   Contribution

   Data curation, Validation

   Competing interests

   No competing interests declared

7. Igor Vorobyov

   1. Department of Physiology and Membrane Biology, University of California, Davis, Davis, United States
   2. Department of Pharmacology, University of California, Davis, Davis, United States

   Contribution

   Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-4767-5297

8. Colleen E Clancy

   Department of Physiology and Membrane Biology, University of California, Davis, Davis, United States

   Contribution

   Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing

   For correspondence

   ceclancy@ucdavis.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-6849-4885

• 1,968

  views

• 21

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.